The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_001754.5(RUNX1):c.249C>T (p.Ala83=)

CA512318889

1153047 (ClinVar)

Gene: RUNX1
Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: 55792a37-c1ea-4f3f-bfd7-8fba9ad57db5

HGVS expressions

NM_001754.5:c.249C>T
NM_001754.5(RUNX1):c.249C>T (p.Ala83=)
NC_000021.9:g.34886945G>A
CM000683.2:g.34886945G>A
NC_000021.8:g.36259242G>A
CM000683.1:g.36259242G>A
NC_000021.7:g.35181112G>A
NG_011402.2:g.1102767C>T
ENST00000675419.1:c.249C>T
ENST00000300305.7:c.249C>T
ENST00000344691.8:c.168C>T
ENST00000358356.9:c.168C>T
ENST00000399237.6:c.213C>T
ENST00000399240.5:c.168C>T
ENST00000437180.5:c.249C>T
ENST00000455571.5:c.210C>T
ENST00000482318.5:c.59-6232C>T
NM_001001890.2:c.168C>T
NM_001122607.1:c.168C>T
NM_001754.4:c.249C>T
NM_001001890.3:c.168C>T
NM_001122607.2:c.168C>T

Likely Benign

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Conflicting Evidence"
Met criteria codes 3
BP7 BP4 PM2_Supporting
Not Met criteria codes 23
BP5 BP2 BP3 BP1 PS2 PS4 PS3 PS1 BA1 PP1 PP4 PP3 PP2 PM1 PM5 PM3 PM4 PM6 PVS1 BS4 BS3 BS1 BS2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Myeloid Malignancy VCEP
NM_001754.5(RUNX1):c.249C>T (p.Ala83=) is a synonymous variant. REVEL score not calculable. SpliceAI predicts: Acceptor loss 0.00, Donor loss 0.00, Acceptor gain 0.00, Donor gain 0.00. (BP4) Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score 0.324528 < 2.0 or the variant is the reference nucleotide in one primate and/or three mammal species) (BP7). PM2_supporting: This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_supporting). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7, PM2_supporting.
Met criteria codes
BP7
Evolutionary conservation prediction algorithms predict the site as not being conserved (PhyloP score 0.324528 < 2.0 or the variant is the reference nucleotide in one primate and/or three mammal species) (BP7).
BP4
REVEL score not calculable. SpliceAI predicts: Acceptor loss 0.00, Donor loss 0.00, Acceptor gain 0.00, Donor gain 0.00. (BP4)
PM2_Supporting
PM2_supporting: This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2).
Not Met criteria codes
BP5
This rule is not applicable for MM-VCEP
BP2
No published literature could be found on this variant
BP3
This rule is not applicable for MM-VCEP
BP1
This rule is not applicable for MM-VCEP
PS2
No published literature could be found on this variant
PS4
No published literature could be found on this variant
PS3
No published literature could be found on this variant
PS1
Synonymous change, not applicable
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No published literature could be found on this variant
PP4
This rule is not applicable for MM-VCEP
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP2
This rule is not applicable for MM-VCEP
PM1
This variant is outside the RHD.
PM5
Synonymous change, not applicable
PM3
This rule is not applicable for MM-VCEP
PM4
Synonymous variant, not applicable
PM6
No published literature could be found on this variant
PVS1
Synonymous change, not applicable
BS4
No published literature could be found on this variant
BS3
No published literature could be found on this variant
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
This rule is not applicable for MM-VCEP
Approved on: 2022-04-25
Published on: 2022-07-05
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.